每年研究成果
每年研究成果
個人檔案
學歷
- 國防醫學院醫學院醫學士
經歷
- 2008.01-2013.07 Director of National Institute of Cancer Research, NHRI
- 2007.08~ Attending Physician of Division of hematology/Oncology, NCKUH
- 2007.08-2013.07 Joined Professor, College of Medicine, National Cheng Kung University
- 2006.01-2007.12 Deputy Director of National Institute of Cancer Research, NHRI
- 2004.06-2008 Chairman of Safety and Data Monitoring committee, TCOG
- 2004.04-2008.08 Investigator of NHRI
- 2003.08-2007.07 Adjunct Professor of Internal Medicine, NDMC (部定，教字013198)
- 2003-2005 常務理事，Chinese Oncology Society
- 2001~ Board member of Chinese Oncology Society
- 2000.09-2004.03 Associate investigator of NHRI
- 1999 ~ Board member of Sino-American Cancer Foundation
- 1997-2006 Adjunct Attending physician of Department of Oncology, NTUH
- 1997~ Senior Attending physician of NHRI
- 1997-2001 General Secretary of Chinese Oncology Society
- 1997 Chief of Hematology / Oncology, Cheng-Hsien Medical
Center - 1994-2003.07 Associate Professor of internal medicine, NDMC (部定，副字 21234)
- 1994-1996 Board member of Chinese BMT Society
- 1993-1996 Chief of Medical Oncology, Tri-Service General Hospital, National Defense Medical Center
- 1991-1992 Attending physician of Medical Mission in Republic of Central Africa
- 1989-1991 Visiting Scholar of Yale Medical School, Department of Pharmacology
- 1987-1989 Fellow of Medical Oncology Training Program of Institute of Biomedical Science, Academia Sinica
- 1987-1996 Attending Physician of Hematology / Oncology, Tri-Service General Hospital, NDMC
- 1986-1987 Chief resident of Division of Hematology / Oncology,
Department of Internal Medicine, TSGH, NDMC - 1982-1986 Resident of Department of Medicine, TSGH, NDMC
- 1981-1982 Internship training, Tri-Service General Hospital
指紋
查看啟用 Jang-Yang Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
Chen, Y. F., Wu, C. H., Chen, L. H., Lee, H. W., Lee, J. C., Yeh, T. K., Chang, J. Y., Chou, M. C., Wu, H. L., Lai, Y. P., Song, J. S., Yeh, K. C., Chen, C. T., Lee, C. J., Shia, K. S. & Shen, M. R., 3月 24 2022, 於: Journal of Medicinal Chemistry. 65, 6, p. 4767-4782 16 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells
Tangeda, V., Lo, Y. K., Babuharisankar, A. P., Chou, H. Y., Kuo, C. L., Kao, Y. H., Lee, A. Y. L. & Chang, J. Y., 3月 2022, 於: Cell Death and Disease. 13, 3, 241.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取3 引文 斯高帕斯（Scopus） -
The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b
Lee, Y. Z., Hsu, H. Y., Yang, C. W., Lin, Y. L., Chang, S. Y., Yang, R. B., Liang, J. J., Chao, T. L., Liao, C. C., Kao, H. C., Chang, J. Y., Sytwu, H. K., Chen, C. T. & Lee, S. J., 7月 2022, 於: Pharmaceutics. 14, 7, 1511.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Tang, Y. C., Chang, H. H., Chen, H. H., Yao, J. Y., Chen, Y. T., Chuang, Y. J., Chang, J. Y. & Kuo, C. C., 2021, 於: Journal of Food and Drug Analysis. 29, 4, 7.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation
Tang, Y. C., Hsiao, J. R., Jiang, S. S., Chang, J. Y., Chu, P. Y., Liu, K. J., Fang, H. L., Lin, L. M., Chen, H. H., Huang, Y. W., Chen, Y. T., Tsai, F. Y., Lin, S. F., Chuang, Y. J. & Kuo, C. C., 3月 11 2021, 於: Theranostics. 11, 11, p. 5232-5247 16 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取29 引文 斯高帕斯（Scopus）